The global market for biopsy devices reached $1.4 billion in 2013. This market is further expected to grow to $1.5 billion in 2014 and $1.9 billion in 2018, a compound annual growth rate (CAGR) of 6.3% over the five year period, 2013 to 2018.
This report provides:
An overview of the global biopsy devices market.
Analyses of global market trends, with data from 2012 and 2013, and projections of compound annual growth rates (CAGRs) through 2018.
Segmented analyses based on devices, therapeutic segments, and geographies.
Analyses of key strategies, competitive insights, and developments of key companies in the market.
Information on both the challenges that must be addressed and opportunities that can be leveraged by market participants.
Evaluation of key and relevant patents.
Comprehensive profiles of leading companies in the industry.
STUDY AND OBJECTIVE
The objective of this report is to:
Assess the dynamics that have significant impact on the growth of the biopsy devices market.
Estimate the biopsy devices market and its sub segments from 2013 through 2018 by procedures and by geographical locations.
Analyze the key strategies, competitive insights and development of key companies in the market.
Provide segmented analysis based on devices, therapeutic segments and geographical locations.
Thoroughly analyze the market trends and technology assessments.
Study intensively the challenges that must be addressed and opportunities that can be leveraged by market participants.
The key criterion for successful cancer treatment is early diagnosis of the disease. However, in the past, it was extremely difficult for doctors to recommend biopsy to patients that were considered low–risk (less probability of positive cancer test, however may need biopsy for confirmation) because a conventional biopsy methods involved complex technical issues along with increased trauma and stress among the patients. However, with the increased adoption of non–invasive methods, the process is now being recommended for low–risk patients as well. This also reduces the stress levels and recovery period of the patients. There are significant novel cancer diagnostic and biopsy methods that are introduced and are evidencing significant growth rate due to increased awareness among the patients.
The report discusses key innovations and market estimations for conventional and advanced biopsy procedures. The report will also capture key market players that are keenly focusing on innovative biopsy procedures.
SCOPE OF THE REPORT
This research report presents an in–depth analysis of the global biopsy devices market by device, therapeutic segments and geographic markets. The report includes key devices such as breast biopsy devices, CNB (core needle biopsy) devices, fine needles, gastro intestinal (GI) biopsy devices, robotic guidance systems technologies involved in thermal ablation techniques and non–thermal ablation techniques. The report will also discuss the market by type of procedure, such as trends and market estimates of key therapeutic areas such as breast cancer, gastro–intestinal cancer, lung cancer, and cervical cancer, among others. The report will focus on key display technologies used in the process of biopsy such as ultrasound, magnetic resonance imaging (MRI), computed tomography (CT) and others. The report also reviews the supply chain from manufacturers to surgeons.
The report excludes drugs used in the process of biopsy and any device that is used in the cancer treatment process.
Biopsy technology and device manufacturers and potential entrants.
Dealers and distributors of biopsy technologies and devices.
Robotics, life science, and surgical companies.
Research institutes, associations and academicians.
SOURCE OF INFORMATION AND METHODOLOGY
The following process was followed to ensure quality and consistency of estimates.
In–depth primary and secondary research.
Primary research included gathering intelligence from key market players. The participants of the interview include CEOs, key opinion leaders, product heads and directors.
Secondary research not only included collation of data from freely available sources, but also from specialized industry magazines and websites.
To best assure triangulation of market estimates the derived values were again validated through primary research.
Key factors considered during market estimations included price, volume, incidence and prevalence rates, and number of procedures among others.